[1]刘 涛,那世杰,庄 宗,等.Pipeline栓塞装置治疗海绵窦段和眼动脉段动脉瘤初步随访分析[J].介入放射学杂志,2018,27(12):1127-1132.
 LIU Tao,NA Shijie,ZHUANG Zong,et al.The application of Pipeline embolization device in treating intracranial aneurysms located between cavernous sinus segment and ophthalmic artery segment[J].journal interventional radiology,2018,27(12):1127-1132.
点击复制

Pipeline栓塞装置治疗海绵窦段和眼动脉段动脉瘤初步随访分析()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
27
期数:
2018年12期
页码:
1127-1132
栏目:
神经介入
出版日期:
2018-12-25

文章信息/Info

Title:
The application of Pipeline embolization device in treating intracranial aneurysms located between cavernous sinus segment and ophthalmic artery segment
作者:
刘 涛 那世杰 庄 宗 凌海平 张庆荣 杭春华
Author(s):
LIU Tao NA Shijie ZHUANG Zong LING Haiping ZHANG Qingrong HANG Chunhua.
Department of Neurosurgery, Affiliated Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province 210000, China
关键词:
【关键词】 Pipeline栓塞装置 海绵窦段动脉瘤 眼动脉段动脉瘤 动脉瘤闭塞率
文献标志码:
A
摘要:
【摘要】 目的 探讨Pipeline栓塞装置(PED)治疗颈内动脉海绵窦段动脉瘤(CCA)和颈内动脉眼动脉段动脉瘤(COA)的安全性和有效性。方法 回顾性分析2015年7月至2016年12月南京鼓楼医院经DSA确诊为CCA、COA及多发动脉瘤并接受PED治疗患者的临床资料。结果 共纳入21例患者(27枚动脉瘤),其中男4例,女17例;年龄27~74岁,平均(57±17)岁;大型/巨大型CCA、COA 15例,多发性COA 5例,微小型COA 1例;平均瘤体直径10.2 mm(2.5~25.3 mm)。术中共植入24枚PED(3例各植入2枚);18例PED结合弹簧圈疏松栓塞,3例仅植入PED。术后即刻造影显示瘤腔内对比剂不同程度滞留,大型/巨大型动脉瘤可见典型“半月征”,载瘤动脉均通畅。术后随访6~12个月,所有患者症状均得到缓解,动脉瘤完全闭塞率为 88.9%(24/27)。结论 PED治疗CCA、COA及多发动脉瘤安全有效,随访结果满意。但仍需大样本远期前瞻性随访验证。

参考文献/References:

[1] 中华医学会神经外科分会神经介入学组. 颅内动脉瘤血管内治疗中国专家共识(2013)[J]. 中华医学杂志, 2013, 93: 3093- 3103.
[2] Hirsch JA, Chandra RV, Leslie- Mazwi TM. Pipeline, aneurysms and the FDA[J]. J Neurointerv Surg, 2012, 4: 314.
[3] 王向阳, 张鸿祺, 支兴龙, 等. 支架辅助弹簧圈栓塞术治疗眼动脉瘤31例[J]. 中国脑血管病杂志, 2010, 7: 428- 431.
[4] Kallmes DF, Hanel R, Lopes D, et al. International retrospective study of the Pipeline embolization device: a multicenter aneurysm treatment study[J]. AJNR Am J Neuroradiol, 2015, 36: 108- 115.
[5] 兰 青, 朱 卿, 许 亮, 等. 锁孔入路在颈内动脉眼动脉段动脉瘤手术中的应用[J]. 中华神经外科杂志, 2015, 31: 895- 898.
[6] Wiebers DO, Whisnant JP, Huston J 3rd, et al. Unruptured intracranial aneurysms: narural history, clinical outcome, and risks of surgical and endovascular tetment[J]. Lancet, 2003, 362: 103- 110.
[7] Fischer S, Perez MA, Kurre W, et al. Pipeline embolization device for the treatment of intra- and extracranial fusiform and dissecting aneurysms: initial experience and long- term follow- up[J]. Neurosurgery, 2014, 75: 364- 374.
[8] ter Brugge KG. Cavernous sinus segment internal carotid artery aneurysms: whether and how to treat[J]. AJNR Am J Neuroradiol, 2012, 33: 327- 328.
[9] Tomasello A, Romero N, Aixut S, et al. Endovascular treatment of intracranial aneurysm with Pipeline embolization device: experience in four centers in Barcelona[J]. Neurol Res, 2016, 38: 381- 388.
[10] Rouchaud A, Brinjikji W, Lanzino G, et al. Delayed hemorrhagic complications after flow diversion for intracranial aneurysms: a literature overview[J]. Neuroradiology, 2016, 58: 171- 177.
[11] Byoun HS, Huh W, Oh CW, et al. Natural history of unruptured intracranial aneurysms: a retrospective single center analysis[J]. J Korean Neurosurg Soc, 2016, 59: 11- 16.
[12] Dolenc VV. Extradural approach to intracavernous ICA aneurysms[J]. Acta Neurochir Suppl, 1999, 72: 99- 106.
[13] Parkinson RJ, Eddleman CS, Batjer HH, et al. Giant intracranial aneurysms: endovascular challenges[J]. Neurosurgery, 2008, 62: 1336- 1345.
[14] Arambepola PK, McEvoy SD, Bulsara KR. De novo aneurysm formation after carotid artery occlusion for cerebral aneurysms[J]. Skull Base, 2010, 20: 405- 408.
[15] Brinjikji W, Murad MH, Lanzino G, et al. Endovascular treatment of intracranial aneurysms with flow diverters: a meta- analysis[J]. Stroke, 2013, 44: 442- 447.
[16] Griessenauer CJ, Piske RL, Baccin CE, et al. Flow diverters for treatment of 160 ophthalmic segment aneurysms: evaluation of safety and efficacy in a multicenter cohort[J]. Neurosurgery, 2017, 80: 726- 732.
[17] Puffer RC, Piano M, Lanzino G, et al. Treatment of cavernous sinus aneurysms with flow diversion: results in 44 patients[J]. AJNR Am J Neuroradiol, 2014, 35: 948- 951.
[18] Zanaty M, Chalouhi N, Starke RM, et al. Flow diversion versus conventional treatment for carotid cavernous aneurysms[J]. Stroke, 2014, 45: 2656- 2661.
[19] Eller JL, Dumont TM, Sorkin GC, et al. The pipeline embolization device for treatment of intracranial aneurysms[J]. Expert Rev Med Devices, 2014, 11: 137- 150.
[20] Raychev R, Tateshima S, Vinuela F, et al. Predictors of thrombotic complications and mass effect exacerbation after Pipeline embolization: the significance of adenosine diphosphate inhibition, fluoroscopy time, and aneurysm size[J]. Interv Neuroradiol, 2016, 22: 34- 41.
[21] Jevsek M, Mounayer C, Seruga T. Endovascular treatment of unruptured aneurysms of cavernous and ophthalmic segment of internal carotid artery with flow diverter device Pipeline[J]. Radiol Oncol, 2016, 50: 378- 384.
[22] 李 航, 白卫星, 贺迎坤, 等. Pipeline栓塞装置治疗颅内动脉瘤术后并发症研究进展[J]. 介入放射学杂志, 2017, 26: 760- 764.
[23] Leung G, Tsang A, Lui WM. Pipeline embolization device for intracranial aneurysm: a systematic review[J]. Clin Neuroradiol, 2012, 22: 295- 303.
[24] Rajah G, Narayanan S, Rangel- Castilla L. Update on flow diverters for the endovascular management of cerebral aneurysms[J]. Neurosurg Focus, 2017, 42: E2.

相似文献/References:

[1]范锋,管生,郭新宾,等.Pipeline栓塞装置治疗颅内复杂动脉瘤临床观察[J].介入放射学杂志,2020,29(01):15.
 FAN Feng,GUAN Sheng,GUO Xinbin,et al.The treatment of complex intracranial aneurysms with Pipeline embolization device: clinical observation[J].journal interventional radiology,2020,29(12):15.

备注/Memo

备注/Memo:
(收稿日期:2017-12-01)
(本文编辑:边 佶)
更新日期/Last Update: 2018-12-20